Recent News

• 02.04.2026 - Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
• 02.02.2026 - Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
• 01.26.2026 - Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
• 01.08.2026 - Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
• 12.29.2025 - Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

Recent Filings

• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 144 Report of proposed sale of securities
• 01.30.2026 - 144 Report of proposed sale of securities